IRIS Accounts Production v24.1.0.578 06474147 Board of Directors 1.2.23 31.1.24 31.1.24 false true false false true false Ordinary A 1.00000 Ordinary B 1.00000 14123 12089 288281 215561 274493 217595 335 14123 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh064741472023-01-31064741472024-01-31064741472023-02-012024-01-31064741472022-01-31064741472022-02-012023-01-31064741472023-01-3106474147ns15:EnglandWales2023-02-012024-01-3106474147ns14:PoundSterling2023-02-012024-01-3106474147ns10:Director12023-02-012024-01-3106474147ns10:PrivateLimitedCompanyLtd2023-02-012024-01-3106474147ns10:SmallEntities2023-02-012024-01-3106474147ns10:AuditExempt-NoAccountantsReport2023-02-012024-01-3106474147ns10:SmallCompaniesRegimeForDirectorsReport2023-02-012024-01-3106474147ns10:SmallCompaniesRegimeForAccounts2023-02-012024-01-3106474147ns10:FullAccounts2023-02-012024-01-3106474147ns10:OrdinaryShareClass12023-02-012024-01-3106474147ns10:OrdinaryShareClass22023-02-012024-01-310647414742ns10:Director22023-01-310647414742ns10:Director22022-01-310647414742ns10:Director22023-02-012024-01-310647414742ns10:Director22022-02-012023-01-310647414742ns10:Director22024-01-310647414742ns10:Director22023-01-3106474147ns5:CurrentFinancialInstruments2024-01-3106474147ns5:CurrentFinancialInstruments2023-01-3106474147ns5:ShareCapital2024-01-3106474147ns5:ShareCapital2023-01-3106474147ns5:RetainedEarningsAccumulatedLosses2024-01-3106474147ns5:RetainedEarningsAccumulatedLosses2023-01-3106474147ns10:RegisteredOffice2023-02-012024-01-3106474147ns5:FurnitureFittings2023-02-012024-01-3106474147ns5:FurnitureFittings2023-01-3106474147ns5:FurnitureFittings2024-01-3106474147ns5:FurnitureFittings2023-01-3106474147ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-01-3106474147ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-01-3106474147ns10:OrdinaryShareClass12024-01-3106474147ns10:OrdinaryShareClass22024-01-3106474147ns10:Director22023-02-012024-01-31064741471ns10:Director12023-01-31064741471ns10:Director12022-01-31064741471ns10:Director12023-02-012024-01-31064741471ns10:Director12022-02-012023-01-31064741471ns10:Director12024-01-31064741471ns10:Director12023-01-31
REGISTERED NUMBER: 06474147 (England and Wales)















Unaudited Financial Statements for the Year Ended 31st January 2024

for

Shoulder And Elbow Clinic Ltd

Shoulder And Elbow Clinic Ltd (Registered number: 06474147)






Contents of the Financial Statements
for the Year Ended 31st January 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


Shoulder And Elbow Clinic Ltd (Registered number: 06474147)

Balance Sheet
31st January 2024

31.1.24 31.1.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 944 1,887

CURRENT ASSETS
Debtors 5 28,033 33,008
Investments 6 16,710 24,440
Cash at bank 128,416 96,444
173,159 153,892
CREDITORS
Amounts falling due within one year 7 57,967 47,373
NET CURRENT ASSETS 115,192 106,519
TOTAL ASSETS LESS CURRENT
LIABILITIES

116,136

108,406

PROVISIONS FOR LIABILITIES 179 359
NET ASSETS 115,957 108,047

CAPITAL AND RESERVES
Called up share capital 8 200 200
Retained earnings 115,757 107,847
SHAREHOLDERS' FUNDS 115,957 108,047

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st January 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st January 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24th October 2024 and were signed on its behalf by:




Dr M S Falworth - Director


Shoulder And Elbow Clinic Ltd (Registered number: 06474147)

Notes to the Financial Statements
for the Year Ended 31st January 2024

1. COMPANY INFORMATION

Shoulder And Elbow Clinic Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 06474147

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 25% on cost

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Shoulder And Elbow Clinic Ltd (Registered number: 06474147)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2024

2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2023 - 2 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1st February 2023
and 31st January 2024 4,825
DEPRECIATION
At 1st February 2023 2,938
Charge for year 943
At 31st January 2024 3,881
NET BOOK VALUE
At 31st January 2024 944
At 31st January 2023 1,887

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade debtors 18,454 24,192
Prepayments and accrued income 9,579 8,816
28,033 33,008

6. CURRENT ASSET INVESTMENTS
31.1.24 31.1.23
£    £   
Unlisted investments 16,710 24,440

The Current Asset Investment represents a 1% share of Elstree Outpatient Centre LLP. As there is no ascertainable market value available, the directors have valued this on a cost basis adjusted for the company's share of the partnership's profits and losses.

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.1.24 31.1.23
£    £   
Trade creditors 4,723 5,246
Tax 49,794 24,890
Directors' current accounts 336 14,123
Accrued expenses 3,114 3,114
57,967 47,373

Shoulder And Elbow Clinic Ltd (Registered number: 06474147)

Notes to the Financial Statements - continued
for the Year Ended 31st January 2024

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.1.24 31.1.23
value: £    £   
100 Ordinary A £1 100 100
100 Ordinary B £1 100 100
200 200

The A Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The B Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A and B Shares rank pari passu in respect of dividend and capital distribution rights.

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st January 2024 and 31st January 2023:

31.1.24 31.1.23
£    £   
Dr M S Falworth and Mrs D J Falworth
Balance outstanding at start of year (14,123 ) (12,089 )
Amounts advanced 288,281 215,561
Amounts repaid (274,493 ) (217,595 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (335 ) (14,123 )

The loan is repayable on demand and no interest was charged during the year.

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Dr M Falworth by virtue of holding 100% of the voting share capital.